ACCEL-LEFLUNOMIDE
Identification of Accel-Leflunomide
| No description |
Google image searchProduct monograph
Active ingredient
leflunomide, 20 MG
DIN: 02478870
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: ACCEL PHARMA INC
Date: 19-SEP-2019
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AK — Dihydroorotate dehydrogenase (DHODH) inhibitors (ATC, ATC/DDD)
- L04AK01 — LEFLUNOMIDE (ATC/DDD)
Reference brand drug: Arava
Pharmaceutical standard: MFR
